Joshua R. Barton
Papers
1
Total Citations
6
H-Index
1
About
Joshua R. Barton is a leading biotechnologist whose work sits at the critical intersection of analytical method development and next-generation vaccine safety. His primary research focuses on the characterization and quality control of mRNA-based therapeutics, specifically addressing the challenges posed by process-related impurities. Barton’s most impactful contribution to date is the development and application of an automated sandwich ELISA for the quantitation of residual double-stranded RNA (dsRNA) in mRNA vaccines. This work, published in 2024, is foundational to the field, providing a robust, high-throughput solution for detecting a key immunogenic byproduct of in vitro transcription. By enabling precise measurement of dsRNA—an impurity that can directly affect both the potency and safety profile of mRNA vaccines—Barton’s method has become an essential tool for manufacturers and regulators alike. Already garnering 6 citations in its first year, this achievement underscores his role in translating complex analytical challenges into practical, scalable solutions that directly support the global deployment of safe and effective mRNA vaccines.
Research Focus
Key Achievements
Top Papers
- 1